Natural Alternatives International trades as part of the consumer packaged goods industry and consumer defensive sector. The company CEO is Mark A. LeDoux. Natural Alternatives International provides contract manufacturing services to companies that market and distribute vitamins, minerals, herbs and other nutritional supplements, as well as other health care products to customers within and outside the U.S.
Previous Intraday Performance:
The NAII shares had a previous change of -1.54% which opened at 11.65 and closed at 11.52. It moved to an intraday high of 11.71 and a low of 11.46.
Over the last five trading days, NAII shares returned -0.52% and in the past 30 trading days it returned 4.23%. Over three months, it changed 11.95%. In one year it has changed -4.00% and within that year its 52-week high was 11.88 and its 52-week low was 8.73. NAII stock is 31.91% above its 52 Week Low.
Our calculations result in a 200 day moving average of 10.23 and a 50 day moving average of 11.12. Right now, NAII stock is trading 12.61% above its 200 day moving average.
The company has a market cap of $86.7m with 7.5m shares outstanding and a float of 6.1m shares. Trading volume was 8,560 shares and has experienced an average volume of 9,836 shares. Our calculation, using the current average volume and close price, leads me to believe that the liquidity is bad, highly speculative and an investor may want to avoid this stock.
The last annual reported EPS for Natural Alternatives International was 0.72 which ended on 30th of June 2018, which according to the previous close, that is a PE of 16.00.
Below was the last reported quarterly earnings per share:
The long-term trend of the EPS is a vital number as it helps understand the future potential of Natural Alternatives International; the EPS growth rate, as it is typically called, is usually expressed as a percentage, which at this time is hard to estimate, but revenue growth has been 16.10% over the last twelve months.
Indicators Also to Watch:
Based on the latest filings, there is 47.90% of institutional ownership.
I calculated the beta to be 0.08
Based on last reported financials, the company’s return on equity is 14.51%, return on assets is 11.13%, profit margin is 6.59%, price-to-sales is 0.61 and price-to-book is 1.17.
Company Score Card:
Results are out of six:
2 : Growth Expectations Result
6 : Financial Safety Result
3 : Past Performance Result
3 : Valuation Result
0 : Dividend Safety Result
3 : Overall Result